Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

$4.7 Million Study Looks at Why Diabetes Makes Heart Disease Worse

Published: Wednesday, July 18, 2012
Last Updated: Wednesday, July 18, 2012
Bookmark and Share
Washington University researchers receives a $4.7 million grant from NHLBI.

Researchers at Washington University School of Medicine in St. Louis have received a $4.7 million grant from the National Heart, Lung, and Blood Institute to investigate heart disease in patients with diabetes.

“Diabetes is an incredibly common problem,” says Jean E. Schaffer, MD, the Virginia Minnich Distinguished Professor of Medicine.

Schaffer continued, “It affects a huge swath of the population. Importantly, people with diabetes don’t just have a metabolic disorder. They develop complications in many organs. And one of the most deadly complications is heart disease. We’re particularly interested in why people with diabetes suffer from unusually severe forms of heart disease.”

For reasons not fully understood, people with diabetes are more likely to develop blockages in arteries.

After a heart attack, the course of the subsequent heart disease is more aggressive than in people without diabetes.

And even independent of blocked arteries, there is evidence that their hearts do not function like those of individuals without diabetes.

According to the Centers for Disease Control and Prevention, almost 26 million Americans are living with type 2 diabetes and another 79 million with undiagnosed diabetes or pre-diabetes, a condition that increases their risk of developing the full-blown variety.

With such statistics, it is becoming increasingly important to explore the reasons behind the aggressive progress of cardiovascular disease in patients whose bodies do not properly regulate blood sugar.

Schaffer and her colleagues suspect a likely culprit is abnormal lipid metabolism. Lipids are a class of molecules that include fats, such as fatty acids and triglycerides.

Past studies have shown that patients with diabetes store higher levels of these lipids in their heart muscle, likely impairing cardiac function.

These lipids appear to lead to inflammation and can also damage important parts of heart cells, such as proteins and DNA, leading to heart muscle dysfunction.

“The problem is that we haven’t been able to make strong links between what we measure in a fasting blood sample, like triglycerides and free fatty acids, and the degree of heart muscle dysfunction,” Schaffer says.

“In this type of heart muscle disorder, these common blood tests are not a good predictor of who is at highest risk for heart disease.”

The goal of the new research program is to identify better measures of heart disease in patients with diabetes. The program has four major parts:

•Establish a clinically useful method to measure key lipids related to diabetes complications in blood samples.

•Identify markers of abnormal lipid metabolism in existing blood samples from clinical trial participants, including those in the Framingham Heart Study. Such large, well-designed clinical trials often have collected both blood samples and non-invasive imaging studies of cardiovascular function such as echocardiograms. Comparing the two may show correlations between markers of abnormal lipid metabolism and heart function.

•Design laboratory experiments, including studies in mouse models of diabetes and heart disease, to help understand how the abnormal lipids may contribute to heart muscle dysfunction.

•Perform a clinical trial for patients with type 2 diabetes to examine whether a drug that lowers blood lipids improves heart function.

In addition to its own research program, Washington University will serve as the coordinating center among the five institutions chosen to receive funding from the National Institutes of Health (NIH) to study the abnormal metabolism of cardiovascular and lung diseases.

The four partnering institutions are Cleveland Clinic, Emory University, National Jewish Health and Weill Cornell Medical College.

“We will be working with the NIH and our partner institutions to help researchers interact and inform new approaches and new ideas in other studies,” Schaffer says.

Schaffer emphasizes the multidisciplinary and collaborative nature of the research program and credits the School of Medicine’s BioMed 21 initiative for providing the resources to facilitate this type of translational project.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Clearance of Key Alzheimer’s Protein Dramatically Slows with Age
Researchers at Washington University School of Medicine in St. Louis have identified some of the key changes in the aging brain that lead to an increased risk of Alzheimer's.
Tuesday, August 11, 2015
Tiny Probes Shine Brightly to Reveal the Location of Targeted Tissues
Called BRIGHTs, the tiny probes described in the online issue of Advanced Materials, bind to biomarkers of disease and, when swept by an infrared laser, light up to reveal their location.
Friday, November 23, 2012
Scientific News
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
A new study led by scientists at The Scripps Research Institute (TSRI) shows that a technology used in thousands of laboratories, called gas chromatography mass spectrometry (GC-MS), fundamentally alters the samples it analyzes.
Newly Identified Biochemical Pathway Could Be Target for Insulin Control
Researchers at Duke Medicine and the University of Alberta are reporting the identification of a new biochemical pathway to control insulin secretion from islet beta cells in the pancreas, establishing a potential target for insulin control.
Dirty,Crusty Meals Fit for (Long-Dormant) Microbes
Researchers apply the latest analytical techniques to further our understanding of desert biocrusts.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Identifying The 'Dimmer Switch' Of Diabetes
University of Alberta research gives new insight into what causes Type 2 diabetes.
10 to 1: Bugs Win in NASA study
Bugs are winning out, and that's a good thing according to NASA's Human Research Program.
MYC Oncogene Disrupts Cancers Rhythm
Findings inform time-dependent treatment for reducing side effects and increasing effectiveness of cancer medications.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos